Real world evidence, digital partnerships and the future of pharmaAhead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & Share XReal world evidence, digital partnerships and the future of pharmahttps://pharmaphorum.com/views-analysis-digital/real-world-evidence-digital-partnerships-and-the-future-of-pharma/
Harnessing data and insights for successAhead of the eyeforpharma Awards shortlist announcement this week, we spoke to judge and commercial insights executive Peter Share XHarnessing data and insights for successhttps://pharmaphorum.com/r-d/views-analysis-r-d/harnessing-data-and-insights-for-success/
Removing logistical barriers to improve clinical trial retentionWe all know how long and arduous the clinical trial road is for sites and sponsors – but Share XRemoving logistical barriers to improve clinical trial retentionhttps://pharmaphorum.com/views-analysis-patients/removing-logistical-barriers-to-improve-clinical-trial-retention/
Rova-T: the story of AbbVie’s multi-billion dollar failureRichard Staines discusses what has become one of the worst deals in pharma’s history – AbbVie’s purchase of Share XRova-T: the story of AbbVie’s multi-billion dollar failurehttps://pharmaphorum.com/r-d/views-analysis-r-d/rova-t-the-story-of-abbvies-multi-billion-dollar-failure/
Delivering innovative therapies with close industry-NHS partnershipsIt was a crucial moment when NHS England and the National Institute for Health and Care Excellence (NICE) Share XDelivering innovative therapies with close industry-NHS partnershipshttps://pharmaphorum.com/r-d/views-analysis-r-d/delivering-innovative-therapies-with-close-industry-nhs-partnerships/
Weekly roundup: More questions for Novartis in Zolgensma scandalIt’s been a tough month for Novartis, with the company facing a deepening scandal over data manipulation for Share XWeekly roundup: More questions for Novartis in Zolgensma scandalhttps://pharmaphorum.com/views-and-analysis/weekly-roundup-more-questions-for-novartis-in-zolgensma-scandal/
Translating microbiome research into treatmentsThe human microbiome is a powerful and dynamic ecosystem of microbes that live on and within our bodies. Share XTranslating microbiome research into treatmentshttps://pharmaphorum.com/r-d/views-analysis-r-d/translating-microbiome-research-into-treatments/
Sharing success to unlock the “triple win” of joint workingThe fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or Share XSharing success to unlock the “triple win” of joint workinghttps://pharmaphorum.com/r-d/views-analysis-r-d/sharing-success-to-unlock-the-triple-win-of-joint-working/
Bringing innovative trials to the UKWe spoke with the National Institute for Health Research’s (NIHR) senior business development manager, Anjna Rising, to learn Share XBringing innovative trials to the UKhttps://pharmaphorum.com/r-d/views-analysis-r-d/bringing-innovative-trials-to-the-uk/
